Table 2.
Common sites of infection in patients with solid tumors
| Infection site | Comments |
|---|---|
| Bloodstream | Often associated with vascular access catheters and neutropenia. Changing epidemiology, with resistant Gram-negative organisms emerging |
| Breast | Generally related to breast cancer surgery, including reconstruction and implants. Changing epidemiology with MRSA and Gram-negative organisms common |
| Bone, cartilage, joints | Often surgery- or prosthetic device-related. May require device removal and/or long-term suppressive therapy |
| Central nervous system | Including ventriculitis, meningitis, shunt-related infections, and post-surgical infections |
| Skin and skin structure | Most often related to surgery, including invasive diagnostic procedures. May be chronic or persistent in irradiated areas. Poly-microbial infections are common |
| Respiratory tract | Aspiration pneumonia in patients with loss of gag reflex or ciliary function. Post-obstructive pneumonia (with empyema or fistula formation with progressive disease) |
| Hepato-biliary pancreatic | Ascending cholangitis (±bacteremia); local abscess formation, reactivation of viral infections (HBV, HCV, CMV) |
| Upper gastro-intestinal | Tracheo-esophageal fistula; percutaneous endoscopic gastrostomy (PEG)-tube-related infection, gastric perforation with abscess formation or peritonitis |
| Lower gastro-intestinal, pelvic | Bowel perforation with peritonitis or abscess formation, neutropenic enterocolitis, Clostridium difficile- or CMV-associated colitis; perirectal/peri-anal infection |
| Genitourinary tract and prostate | Complicated urinary tract infections; obstructive uropathy; prostatitis; abdominal and/or pelvic abscesses |